Creative Planning - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 80 filers reported holding REPROS THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Creative Planning ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$2,000
-66.7%
5,000
-2.0%
0.00%
Q1 2017$6,000
-14.3%
5,1000.0%0.00%
Q4 2016$7,000
-30.0%
5,100
+2.0%
0.00%
Q3 2016$10,000
+25.0%
5,0000.0%0.00%
Q2 2016$8,000
+60.0%
5,0000.0%0.00%
Q1 2016$5,000
-58.3%
5,000
-50.2%
0.00%
Q4 2015$12,000
+1100.0%
10,050
+7235.8%
0.00%
Q3 2015$1,0000.0%137
+37.0%
0.00%
Q1 2015$1,0000.0%1000.0%0.00%
Q4 2014$1,000100
+100.0%
0.00%
Q3 2014$0
-100.0%
500.0%0.00%
Q2 2014$1,0000.0%500.0%0.00%
Q1 2014$1,000500.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 778,800$935,0000.18%
Allegis Investment Advisors, LLC 366,190$439,0000.12%
GENERAL AMERICAN INVESTORS CO INC 589,768$708,0000.07%
Acrospire Investment Management LLC 24,881$30,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 114,165$137,0000.00%
Mariner Wealth Advisors-Cincinnati, LLC 11,000$13,0000.00%
Renaissance Technologies 727,113$873,0000.00%
BALDWIN BROTHERS LLC/MA 1,750$2,0000.00%
VANGUARD GROUP INC 889,850$1,068,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 150$00.00%
View complete list of REPROS THERAPEUTICS INC shareholders